Search Within

Andrew D Seidman

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (25)
  3. Book Section (1)
Groups
  1. Breast Medicine Service (54)
  2. Department of Medicine (54)
  3. Population Sciences Research Program (54)
  4. Solid Tumor Oncology Division (54)
  5. Survivorship Research (49)
  6. Epidemiology and Biostatistics (47)

More Groups

People
  1. Clifford Hudis (29)
  2. Larry Norton (27)
  3. Mark Robson (26)
  4. Katherine Panageas (23)
  5. Gabriella D'Andrea-Carlino (22)
  6. Chau Dang (20)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Breast Cancer Research and Treatment (9)
  3. Clinical Cancer Research (6)
  4. Cancer Research (4)
  5. European Journal of Cancer (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (11)
  3. Springer (11)
  4. Elsevier Inc. (5)
  5. Elsevier Science, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Chew, S. M.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D.; Modi, S.; Seidman, A. D.; Wen, H.; Brogi, E.; Robson, M.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
    Journal Article

    Chew, S. M.; Ferraro, E.; Safonov, A.; Chen, Y.; Kelly, D.; Razavi, P.; Robson, M.; Seidman, A. D.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Yoga for chemotherapy-induced peripheral neuropathy and fall risk: A randomized controlled trial
    Journal Article

    Bao, T.; Zhi, I.; Baser, R.; Hooper, M.; Chen, C.; Piulson, L.; Li, Q. S.; Galantino, M. L.; Blinder, V.; Robson, M.; more...
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save
  • Chemotherapy-induced peripheral neuropathy in breast cancer survivors: Comparison of objective and subjective measures
    Meeting Abstract

    Bao, T.; Kwon, A.; Piulson, L.; Chen, P.; Li, Q.; Patil, S.; Seidman, A.; Blinder, V.; Vahdat, L.; Zhi, W. I.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save